The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

VistaGen Therapeutics, Inc. - Clinically-Focused on Diseases and Disorders Associated with the Central Nervous System

SNNLive spoke with Shawn Singh, CEO of VistaGen Therapeutics, Inc. (NASDAQ: VTGN) at The MicroCap Conference 2016 in Philadelphia, PA.

Share With

Wednesday, November 09, 2016

   

© 2017 Stock News Now